NCT01418118

Brief Summary

Following surgery to remove tumours of the head and neck, patients undergo reconstruction with free flaps - tissue that is taken from elsewhere in the body and given a new blood supply by attaching it to vessels in the neck. Following this type of surgery, patients often need medication to maintain their blood pressure in the intensive care unit. The effect of these drugs on the transplanted tissues is unknown. This study investigates the effects of four commonly used drugs on free flap perfusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 15, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 16, 2011

Completed
Last Updated

August 16, 2011

Status Verified

August 1, 2011

Enrollment Period

1.3 years

First QC Date

August 15, 2011

Last Update Submit

August 15, 2011

Conditions

Keywords

noradrenalinenorepinephrineepinephrineadrenalinedobutaminedopexamineinotropepressorsympathomimeticfree flaptransplantationfree tissue transfermicrosurgerysurvival

Outcome Measures

Primary Outcomes (1)

  • Absolute change in transfer function (flap vascular resistance) after pressor infusion.

    Post infusion (at 4 hours)

Secondary Outcomes (3)

  • Relative change in transfer function after pressor infusion compared with "normal" tissue.

    Post infusion (at 4 hours)

  • Change in flap flow after pressor infusion

    Post infusion (at 4 hours)

  • Differences in frequency spectrum of skin blood flow between flaps and "normal" tissue before and after pressor infusion.

    Post infusion (at 4 hours)

Study Arms (1)

Pressors

EXPERIMENTAL

Epinephrine, Norepinephrine, Dobutamine, Dopexamine

Drug: EpinephrineDrug: NorepinephrineDrug: DobutamineDrug: Dopexamine

Interventions

0.2mcg/kg/min maximum infusion; to increase mean arterial pressure by 30mmHg

Pressors

Maximum infusion of 0.2mcg/kg/min, to increase mean arterial pressure by 30mmHg

Pressors

Maximum infusion rate of 8mcg/kg/min to increase mean arterial pressure by 30mmHg

Pressors

Maximum infusion rate of 5mcg/kg/min to increase mean arterial pressure by 30mmHg

Pressors

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing free tissue transfer surgery at the John Radcliffe Hospital wih planned post-operative admission to the intensive care unit.

You may not qualify if:

  • Pregnancy
  • Weight \>100kg
  • Contraindications to pressor infusions
  • Overnight ventilation not indicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John Radcliffe Hospital

Oxford, Oxfordshire, OX3 9DU, United Kingdom

Location

Related Publications (1)

  • Eley KA, Young JD, Watt-Smith SR. Epinephrine, norepinephrine, dobutamine, and dopexamine effects on free flap skin blood flow. Plast Reconstr Surg. 2012 Sep;130(3):564-570. doi: 10.1097/PRS.0b013e31825dbf73.

MeSH Terms

Conditions

Mouth NeoplasmsHead and Neck NeoplasmsHypotension

Interventions

EpinephrineNorepinephrineDobutaminedopexamine

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsMouth DiseasesStomatognathic DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPhenethylaminesEthylamines

Study Officials

  • Stephen R Watt-Smith, FDSRCS, MD

    Oxford University Hospitals NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 15, 2011

First Posted

August 16, 2011

Study Start

October 1, 2008

Primary Completion

February 1, 2010

Study Completion

February 1, 2010

Last Updated

August 16, 2011

Record last verified: 2011-08

Locations